The interleukin-1 type I receptor is expressed in human hypothalamus

Brain

Volumn 122, Issue 9, 1999, Pages 1697-1707

  Hammond, E A ^a   Smart, D ^a   Toulmond, S ^b   Suman Chauhan, N ^a   Hughes, J ^a   Hall, M D ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b School of Biological Sciences   (United Kingdom)

Author keywords

Cloning; Human; Hypothalamus; IL 1RI; Immunocytochemistry

Indexed keywords

COMPLEMENTARY DNA; INTERLEUKIN 1 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PLASMID VECTOR;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; ASTROCYTE; CENTRAL NERVOUS SYSTEM; CHO CELL; CLONE; CONTROLLED STUDY; CYTOKINE RELEASE; DNA SEQUENCE; ENZYME ACTIVATION; FEMALE; FEVER; FIBROBLAST; GENETIC TRANSFECTION; HYPOTHALAMUS; ILLNESS BEHAVIOR; IMMUNE RESPONSE; IMMUNOCYTOCHEMISTRY; NERVE DEGENERATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STROKE;

ANIMALS; ASTROCYTES; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CHO CELLS; CLONING, MOLECULAR; CRICETINAE; DNA, COMPLEMENTARY; GENETIC VECTORS; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; HYPOTHALAMUS; INTERLEUKIN-1; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RADIOLIGAND ASSAY; RECEPTORS, INTERLEUKIN-1; RECOMBINANT PROTEINS; TRANSFECTION;

EID: 0032852283     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/122.9.1697     Document Type: Article

References (52)

1. Ban EM, Sarlieve LL, Haour FG. Interleukin-1 binding sites on astrocytes Neuroscience 1993; 52: 725-33.
2. Bankers-Fulbright JL, Kalli KR, McKean DJ. Interleukin-1 signal transduction. [Review]. Life Sci 1996; 59: 61-83.
3. Blatteis CM. Neural mechanisms in the pyrogenic and acute-phase responses to interleukin-1. Int J Neurosci 1988; 38: 223-32.
4. Blatteis CM. Neuromodulative actions of cytokines. [Review]. Yale J Biol Med 1990; 63: 133-46.
5. Breder CD, Dinarello CA, Saper CB. Interleukin-1 immunoreactive innervation of the human hypothalamus. Science 1988; 240: 321-4.
6. Chua AO, Gubler U. Sequence of the cDNA for the human fibroblast type interleukin-1 receptor. Nucleic Acids Res 1989; 17: 10114.
7. Colotta F, Orlando S, Fadlon EJ, Sozzani S, Matteucci C, Mantovani A. Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells. J Exp Med 1995; 181: 2181-6.
8. Colotta F, Saccani S, Giri JG, Dower SK, Sims JE, Introna M, et al. Regulated expression and release of the IL-1 decoy receptor in human mononuclear phagocytes. J Immunol 1996; 156: 2534-41.
9. Delgado M, Martinez C, Leceta J, Gomariz RP. Vasoactive intestinal peptide in thymus: synthesis, receptors and biological actions. Neuroimmunomodulation 1999; 6: 97-107.
10. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. [Review]. Blood 1991; 77: 1627-52.
11. Dinarello CA. Biologic basis for interleukin-1 in disease. [Review]. Blood 1996; 87: 2095-147.
12. Freshney NW, Rawlinson L, Guesdon F, Jones E, Cowley S, Hsuan J, et al. Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27. Cell 1994; 78: 1039-49.
13. Giulian D, Tapscott MJ. Immunoregulation of cells within the central nervous system. Brain Behav Immun 1988; 2: 352-8.
14. Giulian D, Woodward J, Young DG, Krebs JF, Lachman LB. Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. J Neurosci 1988; 8: 2485-90.
15. Gould GW, Cuenda A, Thomson FJ, Cohen P. The activation of distinct mitogen-activated protein kinase cascades is required for the stimulation of 2-deoxyglucose uptake by interleukin-1 and insulin-like growth factor-1 in KB cells. Biochem J 1995; 311: 735-8.
16. Greenfeder SA, Nunes P, Kwee L, Labow M, Chizzonite RA, Ju G. Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex. J Biol Chem 1995; 270: 13757-65.
17. Griffin WS, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ, et al. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA 1989; 86: 7611-5.
18. Hallenbeck JM, Dutka AJ, Kochanek PM, Siren A, Pezeshkpour GH, Feuerstein G. Stroke risk factors prepare rat brainstem tissues for modified local Shwartzman reaction. Stroke 1988; 19: 863-9.
19. Han J, Lee JD, Bibbs L, Ulevitch RJ. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 1994; 265: 808-11.
20. Haour F, Marquette C, Ban E, Crumeyroll-Arias MC, Rostene W, Tsiang, H, et al. Receptors for interleukin-1 in the central nervous and neuroendocrine systems. Ann Endocrinol (Paris) 1995; 56: 173-9.
21. Hillier L, Allen M, Bowles L, Dubuque T, Geisel G, Jost S, et al. Stratagene schizo brain S11 Homo sapiens cDNA clone 970980 3' similar to gb:M27492 interleukin-1 receptor, type I precursor (human); contains alu repetitive element; contains element. GenBank 1997; Accession Number AA776138.
22. Hofmeister R, Wiegmann K, Korherr C, Bernardo K, Kronke M, Falk W. Activation of acid sphingomyelinase by interleukin-1 (IL-1) requires the IL-1 receptor accessory protein. J Biol Chem 1997; 272: 27730-6.
23. 3 receptor in Chinese hamster ovary cells characterized by the cellular acidification response using the Cytosensor microphysiometer. Br J Pharmacol 1998; 125: 761-6.
24. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
25. Lechan RM, Toni R, Clark BD, Cannon JG, Shaw AR, Dinarello CA, et al. Immunoreactive interleukin-1 beta localization in the rat forebrain. Brain Res 1990; 514: 135-40.
26. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994; 372: 739-46.
27. Lewis CE. Cytokine production by individual cells. In: Balkwill FR, editor. Cytokines: a practical approach. Oxford: Oxford University Press; 1991. p. 279-97.
28. Kluger MJ. Fever: role of pyrogens and cryogens. [Review]. Physiol Rev 1991; 71: 93-127.
29. Malinowsky D, Lundkvist J, Layé S, Bartfai T. Interleukin-1 receptor accessory protein interacts with the type II interleukin-1 receptor. FEBS Lett 1998; 429: 299-302.
30. McMahan CJ, Slack JL, Mosley B, Cosman D, Lupton SD, Brunton LL, et al. A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J 1991; 10: 2821-32.
31. Mollace V, Colasanti M, Muscoli C, Lauro GM, Iannone M, Rotiroti D, Nistico G. The effect of nitric oxide on cytokine-induced release of PGE2 by human cultured astroglial cells. Br J Pharmacol 1998; 124: 742-6.
32. O'Neill LA. Towards an understanding of the signal transduction pathways for interleukin 1. [Review]. Biochim Biophys Acta 1995; 1266: 31-44.
33. Owicki JC, Parce JW, Kercso KM, Sigal GB, Muir VC, Venter JC, et al. Continuous monitoring of receptor-mediated changes in the metabolic rates of living cells. Proc Natl Acad Sci USA 1990; 87: 4007-11.
34. Pearson VL, Rothwell NJ, Toulmond S. Excitotoxic brain damage in the rat induces interleukin-1 protein in microglia and astrocytes: correlation with the progression of cell death. Glia. In press 1999.
35. Pshenichkin SP, Szekely AM, Wise BC. Transcriptional and posttranscriptional mechanisms involved in the interleukin-1, steroid, and protein kinase C regulation of nerve growth factor in cortical astrocytes. J Neurochem 1994; 63: 419-28.
36. Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch RJ, et al. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 1995; 270: 7420-6.
37. Rothwell NJ. Functions and mechanisms of interleukin 1 in the brain. [Review]. Trends Pharmacol Sci 1991; 12: 430-6.
38. Rothwell NJ. Interleukin-1 and neurodegeneration. Neuroscientist 1998; 4: 195-201.
39. Rothwell NJ, Hopkins SJ. Cytokines and the nervous system II: actions and mechanisms of action [see comments]. [Review]. Trends Neurosci 1995; 18: 130-6. Comment in: Trends Neurosci 1995; 18: 296.
40. Rothwell NJ, Hopkins SJ. Cytokines and the nervous system II: actions and mechanisms of action [see comments]. [Review]. Trends Neurosci 1995; 18: 130-6. Comment in: Trends Neurosci 1995; 18: 296.
41. Rouse J, Cohen P, Trigon S, Morange M, Alonso-Llamazares A, Zamanillo D, et al. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 1994; 78: 1027-37.
42. Rubio N. Demonstration of the presence of an interleukin-1 receptor on the surface of murine astrocytes and its regulation by cytokines and Theiler's virus. Immunology 1994; 82: 178-83.
43. Sambo P, Fadlon EJ, Sironi M, Matteucci C, Introna M, Mantovani A, et al. Reactive oxygen intermediates cause rapid release of the interleukin-1 decoy receptor from human myelomonocytic cells. Blood 1996; 87: 1682-6.
44. Scherle PA, Pratta MA, Feeser WS, Tancula EJ, Arner EC. The effects of IL-1 on mitogen-activated protein kinases in rabbit articular chondrocytes. Biochem Biophys Res Commun 1997; 230: 573-7.
45. Sheng JG, Mrak RE, Griffin WS. Enlarged and phagocytic, but not primed, interleukin-1 alpha-immunoreactive microglia increase with age in normal human brain. Acta Neuropathol (Berl) 1998; 95: 229-34.
46. Sims JE, March CJ, Cosman D, Widmer MB, MacDonald HR, McMahan CJ, et al. cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science 1988; 241: 585-9.
47. Spranger M, Lindholm D, Bandtlow C, Heumann R, Gnahn H, Näher-Noé M, et al. Regulation of nerve growth factor (NGF) synthesis in the rat central nervous system: comparison between the effects of interleukin-1 and various growth factors in astrocyte cultures and in vivo. Eur J Neurosci 1990; 2: 69-76.
48. Szelenyi Z. Neuroglia: possible role in thermogenesis and body temperature control. [Review]. Med Hypotheses 1998; 50: 191-7.
49. Tomozawa Y, Inoue T, Satoh M. Expression of type I interleukin-1 receptor mRNA and its regulation in cultured astrocytes. Neurosci Lett 1995; 195: 57-60.
50. Wesche H, Korherr C, Kracht M, Falk W, Resch K, Martin MU. The interleukin-1 receptor accessory protein (IL-1RAcP) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases). J Biol Chem 1997; 272: 7727-31.
51. Yabuuchi K, Minami M, Katsumata S, Satoh M. Localization of type I interleukin-1 receptor mRNA in the rat brain. Brain Res Mol Brain Res 1994; 27: 27-36.
52. Zervos AS, Faccio L, Gatto JP, Kyriakis JM, Brent R. Mxi2, a mitogen-activated protein kinase that recognizes and phosphorylates Max protein. Proc Natl Acad Sci USA 1995; 92: 10531-4.